Skip to main content
SpringerLink
Log in

Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage

  • Clinical Articles
  • Published:
Acta Neurochirurgica Aims and scope Submit manuscript

Summary

The purpose of this study was to measure plasma platelet-activating factor (PAF) concentration, PAF-acetylhydrolase activities, anti-phospholipid antibody (aPLs) titers, and platelet function in patients with subarachnoid haemorrhage (SAH) and to assess the association of these variables with the development of cerebral vasospasm.

Thirty-two patients with SAH due to ruptured cerebral aneurysm were studied. Plasma PAF concentration, PAF-acetylhydrolase activity, platelet count and aggregability, and plasma factor 4 (PF 4) concentrations were measured regularly until approximately 2 weeks after SAH. aPLs, including lupus anticoagulant and anti-cardiolipin IgG and IgM were measured within 3 days after SAH.

Plasma PAF concentration in patients with SAH showed the highest value on the occasion during 5 to 9 days after SAH. The concentrations were higher in patients with infarction due to vasospasm than in patients without cerebral infarction on any occasions after SAH. Plasma PAF-acetylhydrolase activities did not change in patients, regardless of the presence of cerebral infarction after SAH. Increased platelet consumption and aggregability and higher concentrations of PF 4 were detected in patients with cerebral infarction and not in patients without cerebral infarction. The patients with cerebral infarction due to cerebral vasospasm had aPLs more frequently than the control volunteers.

Our findings indicate that increased plasma PAF and aPLs may contribute to the pathogenesis of cerebral vasospasm after SAH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Ameriso SF, Wong VLY, Ishii H, Quismorio FP, Giannotta SL, Meiselman HJ, Fisher M (1992) Hematogenous factor and prediction of delayed ischemic deficit after subarachnoid hemorrhage. Stroke 23: 1404–1409

    PubMed  Google Scholar 

  2. Blank ML, Snyder F, Byers LW, Brook B, Muirhead (1979) Antihypertensive activity of an alkyl ether analog of phosphatidyl choline. Biochem Biophys Res Commun 90: 1194–1200

    PubMed  Google Scholar 

  3. Bligh EG, Dyer WT (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37: 911–917

    PubMed  Google Scholar 

  4. Bowie EJW, Thompson JH, Cascuzzi PA, Owen (1963) Thrombosis in systemic lupus erythematous despite circulating anticoagulants. J Lab Clin Med 62: 416–430

    PubMed  Google Scholar 

  5. Bradford MM (1976) A rapid sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye-binding. Anal Biochem 72: 248–254

    PubMed  Google Scholar 

  6. Cammussi G, Aglietta M, Coda R, Bussolino F, Piacribello W, Tetta C (1981) Release of platelet-activating factor (PAF) and histamine. II. The cellular origin of human PAF: monocytes, polymorphonuclear neutrophils and basophils. Immunology 42: 191–199

    PubMed  Google Scholar 

  7. Carreras LO, Defreyn G, Machin SV, Vermylen J, Deman R, Spitz B, Van Assche A (1981) Arterial thrombosis, intrauterine death and “lupus” anticoagulant: detection of immunoglobulin interfering with prostacyclin formation. Lancet 31: 244–246

    Google Scholar 

  8. Cazenave JP, Benveniste J, Mustard JF (1979) Aggregation of rabbit platelets by platelet-activating factor is independent of the release the reaction and arachidonate pathway and inhibited by membrane-active drugs. Lab Invest 41: 275–285

    PubMed  Google Scholar 

  9. Chan RC (1984) The role of the prostacyclin-thromboxane system in cerebral vasospasm following induced subarachnoid hemorrhage in the rabbit. J Neurosurg 61: 1120–1128

    PubMed  Google Scholar 

  10. Chap H, Mauco G, Simon MF, Benveniste J, Douste-Blazy L (1981) Biosynthetic labeling of platelet activating factor from radioactive acetate by stimulated platelets. Nature 289: 312–314

    PubMed  Google Scholar 

  11. Feil JM, Flor WJ, Cohan SL, Parkhurst J (1974) Sequential changes of vascular ultrastructure in experimental vasospasm. J Neurosurg 41: 49–58

    PubMed  Google Scholar 

  12. Feuerstein G, Yue TL, Lysko PG (1990) Platelet-activating factor. A putative mediator in central nervous system injury? Stroke 21 [Suppl 11]: III 90-III 94

    Google Scholar 

  13. Findlay SR, Liechtenstein LM, Hanahan DL, Pickard RN (1981) Contraction of guinea pig ileal smooth muscle by acetyl glyceryl ether phosphorylcholine. Am J Physiol 241: C130-C133

    PubMed  Google Scholar 

  14. Fisher CM, Kistler JP, Davis JM (1980) Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery 6: 1–9

    PubMed  Google Scholar 

  15. Fisher M, McGehee W (1985) Cerebral infarct, TIA and lupus inhibitor. Neurology 36: 1234–1237

    Google Scholar 

  16. Freyssinet JM, Wiesel ML, Gauchy J, Boneu B, Cazenave J-P (1986) An IgM lupus anticoagulant that neutralizes the enhancing effect of phospholipid on purified endothelial thrombomodulin activity. A mechanism for thrombosis. Thromb Haemost 53: 309–313

    Google Scholar 

  17. Fukumori T, Tani E, Maeda Y, Sukenaga A (1984) Effect of selective inhibitor of thromboxane A2 synthetase on experimental cerebral vasospasm. Stroke 15: 306–311

    PubMed  Google Scholar 

  18. Hanahan DJ, Weintraub ST (1985) Platelet-activating factor. Isolation, identification and assay. In: Glick D (ed) Methods of isolation, identification and assay. Wiley, New York, pp 195–219

    Google Scholar 

  19. Harris EN, Gharvani AE, Hughes GRV (1985) Anti-phospholipid antibodies. Clin Rheum Dis 11: 591–609

    PubMed  Google Scholar 

  20. Hirashima Y, Endo S, Otsuji T, Karasawa K, Nojima S, Takaku A (1993) Platelet-activating factor and cerebral vasospasm following subarachnoid hemorrhage. J Neurosurg 78: 592–597

    PubMed  Google Scholar 

  21. Hirashima Y, Hayashi N, Endo S, Akira T (1993) Sequential changes in the platelet count in patients with symptomatic vasospasm after subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 33: 220–224

    Google Scholar 

  22. Hirashima Y, Endo S, Ohmori T, Kato R, Takaku A (1994) Platelet activating factor (PAF) concentration and PAF-acetylhydrolase activity in cerebrospinal fluid of patients with subarachnoid hemorrhage. J Neurosurg 80: 31–36

    PubMed  Google Scholar 

  23. Humphrey DM, McManus LM, Hanahan DJ, Pincard RN (1984) Morphologic basis of increased vascular permeability induced by acetyl glyceryl ether phosphorylcholine. Lab Invest 50: 16–25

    PubMed  Google Scholar 

  24. Juvela S, Kaste M, Hillbom M (1985) Effect of nimodipine on platelet function in patients with subarachnoid hemorrhage. Stroke 16: 562–572

    PubMed  Google Scholar 

  25. Kelly PJ, Gorten RJ, Brossman RG, Eisenberg HM (1977) Cerebral perfusion, vascular spasm and outcome in patients with ruptured intracranial aneurysms. J Neurosurg 47: 44–49

    PubMed  Google Scholar 

  26. Miwa M, Miyake T, Yamanaka T, Sugatani J, Suzuki Y, Sakata S, Araki Y, Matsumoto M (1988) Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children. J Clin Invest 82: 1983–1991

    PubMed  Google Scholar 

  27. O'Flaherty JT, Wykle RL, Miller CH, Lewis JC, Waite M, Bass DA, McCall CE, DeChatelet LR (1981) The 1-O-alkyl-sn-glyceryl-3-phosphorylcholines. A novel class of neutrophil stimulation. Am J Pathol 103: 70–78

    PubMed  Google Scholar 

  28. Ohkuma H, Suzuki S, Kimura M, Sobata E (1991) Role of platelet function in symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke 22: 854–858

    PubMed  Google Scholar 

  29. Petruk KC, Weir BK, Overton TR, Marriott MR, Grace MG (1973) The effect of graded hypocapnia and hypercapnia on regional cerebral blood flow and cerebral vessel caliber in the rhesus monkey: study of cerebral hemodynamics following subarachnoid hemorrahge and traumatic internal carotid spasm. Stroke 5: 230–246

    Google Scholar 

  30. Prescott SM, Zimmerman GA, McIntyre TM (1984) Human endothelial cells in culture oroduce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci USA 81: 3534–3538

    PubMed  Google Scholar 

  31. Smith RR, Clower BR, Peeler DF, Yoshioka J (1983) The angiopathy of subarachnoid hemorrhage: angiographic and morphologic correlates. Stroke 14: 240–245

    PubMed  Google Scholar 

  32. Suzuki S, Kimura M, Souma M, Ohkima H, Shimizu T, Iwabuchi T (1990) Cerebral microthrombosis in symptomatic cerebral vasospasm. A quantitative histological study in autopsy cases

  33. Teasdale GM (1988) A universal subarachnoid haemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry 51: 1457–1463

    Google Scholar 

  34. Wardlaw AJ, Moqbel JR, Cromwell O, Kay AB (1986) Plateletactivating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 78: 1701–1706

    PubMed  Google Scholar 

  35. Yamagata S, Kikuchi H, Ihara I, Nagata I, Morooka Y, Naruo Y, Koizumi T, Hashimoto K, Minamikawa J, Miyamoto S, Mitsuno K, Matsumoto M, Yamazoe N, Akiyama Y (1988) Cerebral blood flow as a prognostic indication in subarachnoid hemorrhage. Neurol Med Chir (Tokyo) 28: 333–339

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neurosurgery, Toyama Medical and Pharmaceutical University, Japan

    Y. Hiroshima, S. Endo, M. Kurimoto & A. Takaku

  2. Department of Neurosurgery, Tsukamoto Neurosurgical Hospital, Toyama, Japan

    E. Tsukamoto

Authors
  1. Y. Hiroshima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S. Endo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Kurimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Tsukamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A. Takaku
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hiroshima, Y., Endo, S., Kurimoto, M. et al. Platelet-activating factor and antiphospholipid antibodies in subarachnoid haemorrhage. Acta neurochir 128, 144–149 (1994). https://doi.org/10.1007/BF01400665

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01400665

Keywords

Search

Navigation